Latest Developments in Global Echinococcosis Treatment Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Echinococcosis Treatment Market

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In October 2024, Elanco Animal Health Incorporated announced that the U.S. Food and Drug Administration (FDA) had approved Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), making it the most comprehensive canine oral parasiticide approved to date. It offers protection against six types of parasites, including fleas, ticks, heartworms, and three harmful intestinal parasites—roundworms, hookworms, and tapeworms. Credelio Quattro is a single, monthly chewable tablet designed for dogs aged eight weeks or older